Retinal ganglion cells death in glaucoma - Mechanism and potential treatment. Part I;Śmierć komórek zwojowych siatkówki w przebiegu jaskry - Patomechanizm i potencjalne możliwości leczenia. Czȩść I

Klinika Oczna

Volumn 109, Issue 7-9, 2007, Pages 349-352

  Rokicki, Wojciech ^b,c   Dorecka, Mariola ^a   Romaniuk, Wanda ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b Wojewódzkiego Szpitala Specjalistycznego nr 5 Im w Barbary   (Poland)

^c Wojewódzki Szpital Specjalistyczny nr 5 Im Sw Barbary   (Poland)

Author keywords

Apoptosis; Glaucoma; Neuroprotection; Retinal ganglion cell

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; NEUROPROTECTIVE AGENT;

APOPTOSIS; DRUG EFFECT; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; MALE; METABOLISM; OPTIC NERVE DISEASE; PATHOLOGY; RETINA GANGLION CELL; REVIEW;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; MALE; NEUROPROTECTIVE AGENTS; OPTIC NERVE DISEASES; RETINAL GANGLION CELLS;

EID: 35348948639     PISSN: 00232157     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Tezel G, Wax MB: Increased production of tumor necrosis factor-alpha by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells. J Neurosci 2000, 20, 8693-8700.
2. Sadun AA: Mitochondrial optic neuropathies. J Neurol Neurosurg Psychiatry 2002, 72, 423-425.
3. Oku H, Sugiyama T, Kojima S, Watanabe T, Azuma I: . Experimental optic cup enlargement caused by endothelin-1-induced chronic optic nerve head ischemia. Surv Ophthalmol 1999, 44, 74-84.
4. Koss MC.: Functional role of nitric oxide in regulation of ocular blood flow. Eur J Pharmacol 1999, 374, 161-174.
5. Tezel G, Wax MB: Hypoxia-inducible factor 1 alpha in the glaucomatous retina and optic nerve head. Arch Ophthalmol 2004, 122, 1348-1356.
6. Kitazawa Y, Shirai H, Go FJ: The effect of Ca2(+) -antagonist on visual field in low-tension glaucoma. Graefes Arch Clin Exp Ophthalmol. 1989, 227, 408-412.
7. Netland PA, Chaturvedi N, Dreyer EB: .Calcium channel blockers in the management of low-tension and open-angle glaucoma. Am J Ophthalmol 1993, 115, 608-613.
8. Burke J, Schwartz M: Preclinical evaluation of brimonidine. Surv Ophthalmol. 1996, 41, 9-18.
9. Osborne NN, Cazevieille C, Carvalho AL, Larsen AK, DeSantis L.: In vivo and in vitro experiments show that betaxolol is a retinal neuroprotective agent. Brain Res 1997, 751, 113-123.
10. Chung HS, Harris A, Kristinsson JK, Ciulla TA, Kagemann C, Ritch R: Ginkgo biloba extract increased ocular blood flow velocity. J Ocul Pharmacol Ther 1999, 15, 233-240.
11. Pease ME, McKinnon SJ, Quigley HA, Kerrigan-Baumrind LA, Zack DJ: Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma. Invest Ophthalmol Vis Sci. 2000, 41, 764-774.
12. Johnson EC, Deppmeier LM, Wentzien SK, Hsu I, Morrison JC: Chronology of optic nerve head and retinal responses to elevated intraocular pressure. Invest Ophthalmol Vis Sci. 2000, 41, 431-442.
13. Ji JZ, Elyaman W, Yip HK, Lee VW, Yick LW, Hugon J, So KF: CNTF promotes survival of retinal ganglion cells after induction of ocular hypertension in rats: the possible involvement of STAT3 pathway. Eur J Neurosci. 2004, 19, 265-272.
14. Qin Q, Patil K, Sharma SC: The role of Bax-inhibiting peptide in retinal ganglion cell apoptosis after optic nerve transection. Neurosci Lett. 2004, 372, 17-21.
15. Lingor P, Koeberle P, Kugler S, Bahr M: Down-regulation of apoptosis mediators by RNAi inhibits axotomy-induced retinal ganglion cell death in vivo. Brain. 2005, 128, 550-558.